Advances in Lung Transplantation: From Donor to Recipient

  

Jonathan D’Cunha, MD, PhD, FACS

Johnathon D’Cunha, MD, PhD, serves as the Surgical Director for the University of Pittsburgh Medical Center’s Lung Transplant and Extra Corporeal Membrane Oxygenation (ECMO) Programs. Dr. D’Cunha received his BA in molecular biology degree from the University of Wisconsin and his MD and PhD (in microbiology) at the Medical College of Wisconsin. He completed his surgical residency at the University of Minnesota and went on to complete his fellowship in cardiovascular and thoracic surgery.

Dr. D’Cunha’ s research interests include ex-vivo lung perfusion, graft preservation, and genetic expression of thoracic metastatic disease. He has authored, or co-authored, over 275 publications, and as one could imagine, is an avid Green Bay Packers fan.

Matthew Ricks Morrell, MD

Matthew Morrell, MD, serves as the Medical Director for the University of Pittsburgh Medical Center’s Lung Transplant Program, as well as the Medical Director for the Center for Organ Recovery and Education (CORE). He graduated summa cum laude from the University of Utah with a BS in chemistry. Afterwards, he attended the University of California in Los Angeles School of Medicine where he received his Doctor of Medicine degree and was elected to the Alpha Omega Alpha Honor Society.  He then completed both his residency in Internal Medicine and fellowship in Pulmonary and Critical Care at Washington University in St. Louis/Barnes-Jewish Hospital.  During this time he was awarded the Shatz-Strauss Teaching Award and the Washington University School of Medicine Resident of the Year Award. 

Dr. Morrell’s main interests are concentrated on the care of pulmonary transplant recipients and patients with end-stage lung disease. Dr. Morrell also serves at the Director of the Lung Transplant Fellowship here at the University of Pittsburgh. His research interests include novel therapies for bronchiolitis obliterans syndrome (BOS), extracorporeal photopheresis (ECP), and acute antibody mediated rejection.